Rabeximod

CAS No. 872178-65-9

Rabeximod( —— )

Catalog No. M34686 CAS No. 872178-65-9

Rabeximod is a potent immunomodulator that reduces the severity of autoimmune diseases in rat models.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 257 In Stock
10MG 364 In Stock
25MG 549 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Rabeximod
  • Note
    Research use only, not for human use.
  • Brief Description
    Rabeximod is a potent immunomodulator that reduces the severity of autoimmune diseases in rat models.
  • Description
    Rabeximod is a potent immunomodulator that reduces the severity of autoimmune diseases in rat models. Rabeximod inhibits arthritis in a time-dependent manner by stimulating TLR2 and TLR4 downstream to block the activation of inflammatory cells, most likely macrophages. Rabeximod effectively reduces brain antigen presentation in mice during anti-inflammatory therapy for traumatic brain injury.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    TLR
  • Recptor
    TLR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    872178-65-9
  • Formula Weight
    409.91
  • Molecular Formula
    C22H24ClN5O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C(NCCN(C)C)=O)N1C=2C(C=3C1=CC=C(Cl)C3)=NC=4C(N2)=CC(C)=C(C)C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • ANA975

    ANA975 is an oral prodrug of the TLR-7 agonist Isatoribine (ANA245;7-Thia-8-oxoguanosine) against hepatitis C virus (HCV) infection.

  • SM 324405

    SM 324405 is an ?agonist of TLR7.

  • Gardiquimod

    Gardiquimod could inhibit HIV-1 infection of macrophages and activated peripheral blood mononuclear cells.